

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.20246412 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.20246412 |
| 3 | cellular response to type I interferon (GO:0071357) | 5.97334206 |
| 4 | type I interferon signaling pathway (GO:0060337) | 5.97334206 |
| 5 | response to type I interferon (GO:0034340) | 5.93310129 |
| 6 | positive regulation of interferon-alpha production (GO:0032727) | 5.77970568 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.69090702 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.69090702 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.69090702 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.69090702 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.69090702 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.69090702 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.56894014 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 5.53786455 |
| 15 | response to interferon-alpha (GO:0035455) | 5.31551552 |
| 16 | negative regulation of viral genome replication (GO:0045071) | 5.05484589 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90980105 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.89759019 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.62565208 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.60488914 |
| 21 | response to interferon-beta (GO:0035456) | 4.57134078 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.56437875 |
| 23 | response to peptidoglycan (GO:0032494) | 4.45946465 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.26479788 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.26165032 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.22265941 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 4.16916993 |
| 28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.13567660 |
| 29 | positive regulation of interferon-beta production (GO:0032728) | 4.11146017 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.08318633 |
| 31 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.07379869 |
| 32 | response to host immune response (GO:0052572) | 4.03294032 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.03294032 |
| 34 | lymphocyte chemotaxis (GO:0048247) | 4.01919722 |
| 35 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.98791712 |
| 36 | cellular response to exogenous dsRNA (GO:0071360) | 3.96071796 |
| 37 | cellular response to interferon-beta (GO:0035458) | 3.87397657 |
| 38 | T-helper 1 type immune response (GO:0042088) | 3.81249058 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.81039168 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81039168 |
| 41 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.75210007 |
| 42 | cellular response to interferon-alpha (GO:0035457) | 3.73323316 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.65736462 |
| 44 | response to host (GO:0075136) | 3.62638849 |
| 45 | response to host defenses (GO:0052200) | 3.62638849 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.62638849 |
| 47 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.62182725 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.59990730 |
| 49 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.59944210 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 3.59944210 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.58480423 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.57620301 |
| 53 | detection of other organism (GO:0098543) | 3.57078524 |
| 54 | regulation of chemokine biosynthetic process (GO:0045073) | 3.53397750 |
| 55 | regulation of vitamin metabolic process (GO:0030656) | 3.52983116 |
| 56 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.52765490 |
| 57 | cellular response to interferon-gamma (GO:0071346) | 3.49899417 |
| 58 | germinal center formation (GO:0002467) | 3.47824884 |
| 59 | B cell mediated immunity (GO:0019724) | 3.47355507 |
| 60 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.46849296 |
| 61 | positive regulation of heat generation (GO:0031652) | 3.46594168 |
| 62 | T cell migration (GO:0072678) | 3.46577047 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.45375180 |
| 64 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.43268673 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.41262764 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41040397 |
| 67 | respiratory burst (GO:0045730) | 3.41022589 |
| 68 | cellular response to virus (GO:0098586) | 3.39897958 |
| 69 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.39845104 |
| 70 | regulation of podosome assembly (GO:0071801) | 3.39262251 |
| 71 | detection of bacterium (GO:0016045) | 3.39111459 |
| 72 | regulation of RIG-I signaling pathway (GO:0039535) | 3.36119129 |
| 73 | defense response to virus (GO:0051607) | 3.35307078 |
| 74 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.35136641 |
| 75 | regulation of fever generation (GO:0031620) | 3.34210901 |
| 76 | regulation of type 2 immune response (GO:0002828) | 3.33488147 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 3.32314302 |
| 78 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.28941302 |
| 79 | interferon-gamma secretion (GO:0072643) | 3.28167212 |
| 80 | response to interferon-gamma (GO:0034341) | 3.27730516 |
| 81 | detection of external biotic stimulus (GO:0098581) | 3.26769307 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25380056 |
| 83 | granulocyte activation (GO:0036230) | 3.23329033 |
| 84 | regulation of mononuclear cell migration (GO:0071675) | 3.21835039 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.21189620 |
| 86 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.16323000 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 3.15029704 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 3.14853362 |
| 89 | regulation of interferon-beta production (GO:0032648) | 3.14628771 |
| 90 | positive regulation of interleukin-12 production (GO:0032735) | 3.14091311 |
| 91 | positive regulation of T cell cytokine production (GO:0002726) | 3.10531113 |
| 92 | negative regulation of viral process (GO:0048525) | 3.08794117 |
| 93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07895279 |
| 94 | microglial cell activation (GO:0001774) | 3.07622392 |
| 95 | eosinophil chemotaxis (GO:0048245) | 3.07110535 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 3.04449694 |
| 97 | monocyte chemotaxis (GO:0002548) | 3.03531538 |
| 98 | regulation of chronic inflammatory response (GO:0002676) | 3.03432779 |
| 99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.03082828 |
| 100 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00066779 |
| 101 | * myeloid dendritic cell differentiation (GO:0043011) | 2.98911191 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96148337 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.94974529 |
| 104 | neutrophil activation (GO:0042119) | 2.94314117 |
| 105 | positive regulation of acute inflammatory response (GO:0002675) | 2.93235346 |
| 106 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92916368 |
| 107 | regulation of viral genome replication (GO:0045069) | 2.92805655 |
| 108 | positive regulation of lymphocyte migration (GO:2000403) | 2.91389793 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90490317 |
| 110 | response to exogenous dsRNA (GO:0043330) | 2.90092260 |
| 111 | regulation of tolerance induction (GO:0002643) | 2.88790406 |
| 112 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88718247 |
| 113 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.88506158 |
| 114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88358637 |
| 115 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.88054883 |
| 116 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.88001603 |
| 117 | * response to protozoan (GO:0001562) | 2.87457748 |
| 118 | positive regulation of interleukin-17 production (GO:0032740) | 2.86308206 |
| 119 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.84910573 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84910109 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.84904523 |
| 122 | regulation of interleukin-17 production (GO:0032660) | 2.82797784 |
| 123 | macrophage activation (GO:0042116) | 2.82626518 |
| 124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81344126 |
| 125 | regulation of T-helper cell differentiation (GO:0045622) | 2.80713710 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80371596 |
| 127 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.78141955 |
| 128 | positive regulation of interleukin-6 production (GO:0032755) | 2.76479671 |
| 129 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75834026 |
| 130 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.73375070 |
| 131 | positive regulation of chemokine production (GO:0032722) | 2.72397904 |
| 132 | positive regulation of tolerance induction (GO:0002645) | 2.72122319 |
| 133 | * defense response to protozoan (GO:0042832) | 2.71913767 |
| 134 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.71194690 |
| 135 | eosinophil migration (GO:0072677) | 2.68739246 |
| 136 | cellular response to lipopolysaccharide (GO:0071222) | 2.68062347 |
| 137 | regulation of cholesterol storage (GO:0010885) | 2.67340388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.47382996 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.95782847 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.56204306 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.74000498 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.66386448 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.17923513 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45128733 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36523971 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00546991 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.77326662 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75656121 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.69394261 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59702153 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59356667 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57120629 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53680642 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.47570285 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35563076 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30086156 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27751509 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13037931 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07785378 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06229521 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03946516 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75487462 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72457808 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71836683 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71594928 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70890538 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61358013 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55412862 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55274713 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48390661 |
| 34 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48043529 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47805705 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.47064520 |
| 37 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46649453 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38468931 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38285240 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.36552904 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34301101 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30588165 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29405612 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24506391 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.24418955 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23983963 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23444970 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22739687 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21120608 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20010351 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18345976 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18185525 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17468322 |
| 54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15904518 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14324770 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14169272 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14056376 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13729498 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13301072 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12888423 |
| 61 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12768146 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11226709 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11141784 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10568563 |
| 65 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10279487 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09599437 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09502814 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.09292716 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08036776 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.08005931 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07321469 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07231069 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06245964 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06049320 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05618682 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04339079 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02145449 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00354307 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98092694 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 0.97583930 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95975364 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95672473 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95099488 |
| 84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94752541 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92083574 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91476743 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91105646 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91097111 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91040317 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90574349 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88955850 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88535226 |
| 93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87761718 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 0.86567556 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85363684 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85207813 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85038385 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83773423 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81245273 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79852609 |
| 101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78839070 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78491043 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77513724 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75916537 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74504260 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74233974 |
| 107 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72187708 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71984599 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71961925 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70104015 |
| 111 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70067919 |
| 112 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.69867418 |
| 113 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.68931033 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.67513206 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67084933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35862717 |
| 2 | MP0009785_altered_susceptibility_to | 4.13559172 |
| 3 | MP0003724_increased_susceptibility_to | 3.64553022 |
| 4 | MP0006082_CNS_inflammation | 3.62494016 |
| 5 | MP0003436_decreased_susceptibility_to | 3.36709450 |
| 6 | MP0003303_peritoneal_inflammation | 3.36606715 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.35038657 |
| 8 | MP0005025_abnormal_response_to | 3.09791331 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.09041739 |
| 10 | MP0004510_myositis | 2.99584500 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.90597678 |
| 12 | MP0001790_abnormal_immune_system | 2.89418148 |
| 13 | MP0005387_immune_system_phenotype | 2.89418148 |
| 14 | MP0002419_abnormal_innate_immunity | 2.77924114 |
| 15 | MP0000685_abnormal_immune_system | 2.58440292 |
| 16 | MP0005451_abnormal_body_composition | 2.49725911 |
| 17 | MP0005671_abnormal_response_to | 2.49637012 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.38294492 |
| 19 | MP0009840_abnormal_foam_cell | 2.34493950 |
| 20 | MP0001800_abnormal_humoral_immune | 2.32938550 |
| 21 | MP0002723_abnormal_immune_serum | 2.31932121 |
| 22 | MP0004947_skin_inflammation | 2.30644043 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.27323135 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.22096982 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.07847868 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.04183501 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.03226006 |
| 28 | MP0001819_abnormal_immune_cell | 2.00741306 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.94809867 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.93618588 |
| 31 | MP0008004_abnormal_stomach_pH | 1.88128621 |
| 32 | MP0004858_abnormal_nervous_system | 1.87326412 |
| 33 | MP0009764_decreased_sensitivity_to | 1.81237181 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.80290709 |
| 35 | MP0003075_altered_response_to | 1.79646433 |
| 36 | MP0008469_abnormal_protein_level | 1.79134222 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.72208254 |
| 38 | MP0001853_heart_inflammation | 1.66459016 |
| 39 | MP0000343_altered_response_to | 1.64386669 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.57585135 |
| 41 | MP0003448_altered_tumor_morphology | 1.57181334 |
| 42 | MP0000604_amyloidosis | 1.55532334 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.49987533 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.46635158 |
| 45 | MP0005310_abnormal_salivary_gland | 1.45928619 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.44623257 |
| 47 | MP0002006_tumorigenesis | 1.42346656 |
| 48 | MP0000716_abnormal_immune_system | 1.42204511 |
| 49 | MP0002405_respiratory_system_inflammati | 1.41591835 |
| 50 | MP0005083_abnormal_biliary_tract | 1.39058842 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.37254511 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.35792905 |
| 53 | MP0002398_abnormal_bone_marrow | 1.31110016 |
| 54 | MP0005166_decreased_susceptibility_to | 1.29328059 |
| 55 | MP0009278_abnormal_bone_marrow | 1.29144328 |
| 56 | MP0001873_stomach_inflammation | 1.28123175 |
| 57 | MP0010307_abnormal_tumor_latency | 1.25416761 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.23845693 |
| 59 | MP0002254_reproductive_system_inflammat | 1.22876121 |
| 60 | MP0005164_abnormal_response_to | 1.20056656 |
| 61 | MP0001663_abnormal_digestive_system | 1.17349991 |
| 62 | MP0002429_abnormal_blood_cell | 1.15535242 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.12416719 |
| 64 | MP0000490_abnormal_crypts_of | 1.11240707 |
| 65 | MP0006054_spinal_hemorrhage | 1.09681689 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.09297051 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.09297051 |
| 68 | MP0003866_abnormal_defecation | 1.06681598 |
| 69 | MP0003690_abnormal_glial_cell | 1.04749320 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.03776514 |
| 71 | MP0005360_urolithiasis | 1.01667171 |
| 72 | MP0003195_calcinosis | 1.01458046 |
| 73 | MP0004883_abnormal_blood_vessel | 0.99276036 |
| 74 | MP0002722_abnormal_immune_system | 0.98359362 |
| 75 | MP0009763_increased_sensitivity_to | 0.95031688 |
| 76 | MP0000858_altered_metastatic_potential | 0.93406575 |
| 77 | MP0001851_eye_inflammation | 0.90643445 |
| 78 | MP0003186_abnormal_redox_activity | 0.89928354 |
| 79 | MP0005390_skeleton_phenotype | 0.89924378 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.80694433 |
| 81 | MP0000249_abnormal_blood_vessel | 0.80269571 |
| 82 | MP0001542_abnormal_bone_strength | 0.79940958 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.79143631 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.78684782 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.77944213 |
| 86 | MP0003828_pulmonary_edema | 0.76528356 |
| 87 | MP0005023_abnormal_wound_healing | 0.76394240 |
| 88 | MP0008874_decreased_physiological_sensi | 0.76122308 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.76013764 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.74731246 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.72719148 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.71330350 |
| 93 | MP0005165_increased_susceptibility_to | 0.70767868 |
| 94 | MP0002933_joint_inflammation | 0.70357503 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.69392211 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.68979572 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68793757 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.68390586 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.68315097 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.68186259 |
| 101 | MP0003646_muscle_fatigue | 0.67066413 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.66704696 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.64579508 |
| 104 | MP0001666_abnormal_nutrient_absorption | 0.64167508 |
| 105 | MP0003879_abnormal_hair_cell | 0.63707900 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.62285013 |
| 107 | MP0003045_fibrosis | 0.61722863 |
| 108 | MP0008873_increased_physiological_sensi | 0.61534827 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.61463681 |
| 110 | MP0000609_abnormal_liver_physiology | 0.60618299 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.58974316 |
| 112 | MP0008260_abnormal_autophagy | 0.56510274 |
| 113 | MP0003795_abnormal_bone_structure | 0.53411656 |
| 114 | MP0003091_abnormal_cell_migration | 0.51903258 |
| 115 | MP0003329_amyloid_beta_deposits | 0.51452758 |
| 116 | MP0001849_ear_inflammation | 0.51356750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.92295251 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.56936458 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.46917546 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.46321785 |
| 5 | Chronic otitis media (HP:0000389) | 5.29160219 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.99653788 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.70913774 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.70401041 |
| 9 | Orchitis (HP:0100796) | 4.57722481 |
| 10 | Myositis (HP:0100614) | 4.56819050 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.52234583 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.95055835 |
| 13 | Prostate neoplasm (HP:0100787) | 3.92762831 |
| 14 | Pustule (HP:0200039) | 3.86617138 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.86440627 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 3.83589110 |
| 17 | Nasal polyposis (HP:0100582) | 3.78710892 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.73692000 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.69116835 |
| 20 | Optic neuritis (HP:0100653) | 3.69116835 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.59100463 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 3.54248369 |
| 23 | Recurrent skin infections (HP:0001581) | 3.41496053 |
| 24 | Vasculitis (HP:0002633) | 3.37762249 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.35031278 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.33219388 |
| 27 | Gingivitis (HP:0000230) | 3.30707447 |
| 28 | Axonal loss (HP:0003447) | 3.30131973 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.28109383 |
| 30 | Recurrent viral infections (HP:0004429) | 3.27866815 |
| 31 | Tetraparesis (HP:0002273) | 3.24905664 |
| 32 | Petechiae (HP:0000967) | 3.12182742 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.98474764 |
| 34 | Increased IgM level (HP:0003496) | 2.95742211 |
| 35 | Premature loss of primary teeth (HP:0006323) | 2.93039707 |
| 36 | Periodontitis (HP:0000704) | 2.90806004 |
| 37 | Stomatitis (HP:0010280) | 2.87158054 |
| 38 | Loss of speech (HP:0002371) | 2.84474326 |
| 39 | Gangrene (HP:0100758) | 2.80462826 |
| 40 | Malnutrition (HP:0004395) | 2.76595356 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.76347986 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.74381076 |
| 43 | Encephalitis (HP:0002383) | 2.70836243 |
| 44 | Cellulitis (HP:0100658) | 2.68995529 |
| 45 | Glomerulonephritis (HP:0000099) | 2.67002218 |
| 46 | Progressive neurologic deterioration (HP:0002344) | 2.61260739 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.58125734 |
| 48 | Chronic sinusitis (HP:0011109) | 2.57561182 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.49580732 |
| 50 | Urticaria (HP:0001025) | 2.49529853 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.48224783 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.46423270 |
| 53 | Obstructive lung disease (HP:0006536) | 2.45934039 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45934039 |
| 55 | Increased IgE level (HP:0003212) | 2.44279110 |
| 56 | Leukocytosis (HP:0001974) | 2.40900030 |
| 57 | Hematochezia (HP:0002573) | 2.40802800 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40517840 |
| 59 | Increased serum ferritin (HP:0003281) | 2.36991027 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36003122 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36003122 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36003122 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.35299847 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35299847 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.34936979 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.34272473 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34206056 |
| 68 | Nausea (HP:0002018) | 2.34012249 |
| 69 | Disinhibition (HP:0000734) | 2.32607779 |
| 70 | Pulmonary embolism (HP:0002204) | 2.32604477 |
| 71 | Complement deficiency (HP:0004431) | 2.32033661 |
| 72 | Bone pain (HP:0002653) | 2.31805774 |
| 73 | Porencephaly (HP:0002132) | 2.29523054 |
| 74 | Nephritis (HP:0000123) | 2.26466425 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26258862 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26258862 |
| 77 | Colitis (HP:0002583) | 2.26186784 |
| 78 | Episodic fever (HP:0001954) | 2.25727308 |
| 79 | Nuclear cataract (HP:0100018) | 2.24737651 |
| 80 | Gingival bleeding (HP:0000225) | 2.24692859 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.23952925 |
| 82 | Purpura (HP:0000979) | 2.23277589 |
| 83 | Acne (HP:0001061) | 2.22473619 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21585699 |
| 85 | Arterial thrombosis (HP:0004420) | 2.20836068 |
| 86 | Esophageal neoplasm (HP:0100751) | 2.20118385 |
| 87 | Neoplasm of head and neck (HP:0012288) | 2.20118385 |
| 88 | Osteomyelitis (HP:0002754) | 2.18380927 |
| 89 | Abnormality of complement system (HP:0005339) | 2.17258027 |
| 90 | Spontaneous hematomas (HP:0007420) | 2.17091515 |
| 91 | Polyneuropathy (HP:0001271) | 2.16380875 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15934719 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15934719 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15934719 |
| 95 | Thick nail (HP:0001805) | 2.15708353 |
| 96 | Joint swelling (HP:0001386) | 2.15426908 |
| 97 | Hemoptysis (HP:0002105) | 2.15042372 |
| 98 | Poor head control (HP:0002421) | 2.14060484 |
| 99 | Mutism (HP:0002300) | 2.13606084 |
| 100 | Peritonitis (HP:0002586) | 2.12020803 |
| 101 | Parakeratosis (HP:0001036) | 2.10829260 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.10800695 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.09401264 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.09207520 |
| 105 | Anorexia (HP:0002039) | 2.07873308 |
| 106 | Progressive visual loss (HP:0000529) | 2.06883861 |
| 107 | Vertigo (HP:0002321) | 2.06616987 |
| 108 | Abnormality of T cell number (HP:0011839) | 2.05547471 |
| 109 | Abnormality of the endocardium (HP:0004306) | 2.03867136 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.03331867 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.02321079 |
| 112 | T lymphocytopenia (HP:0005403) | 2.01064936 |
| 113 | Recurrent pneumonia (HP:0006532) | 2.00261007 |
| 114 | Meningitis (HP:0001287) | 1.99926606 |
| 115 | Osteolytic defects of the hand bones (HP:0009699) | 1.99174275 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99174275 |
| 117 | Amyloidosis (HP:0011034) | 1.98488913 |
| 118 | Abnormality of the pericardium (HP:0001697) | 1.97647701 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.96502574 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.96502574 |
| 121 | Glomerulopathy (HP:0100820) | 1.95470571 |
| 122 | Cheilitis (HP:0100825) | 1.95121904 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95080015 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.94953904 |
| 125 | Myocardial infarction (HP:0001658) | 1.90362368 |
| 126 | Keratitis (HP:0000491) | 1.89341003 |
| 127 | Polygenic inheritance (HP:0010982) | 1.89038474 |
| 128 | Polycythemia (HP:0001901) | 1.88608352 |
| 129 | Apathy (HP:0000741) | 1.88149066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 3.98286531 |
| 2 | MST1R | 3.83981575 |
| 3 | ERN1 | 3.81666990 |
| 4 | TYK2 | 3.56250649 |
| 5 | BLK | 3.33858423 |
| 6 | IKBKE | 3.30364296 |
| 7 | MAP3K14 | 3.04209492 |
| 8 | MAP4K1 | 2.86391192 |
| 9 | KIT | 2.86329198 |
| 10 | PBK | 2.70371343 |
| 11 | RIPK4 | 2.43514195 |
| 12 | TAOK2 | 2.41154819 |
| 13 | IRAK4 | 2.32703665 |
| 14 | PIM2 | 2.30059683 |
| 15 | JAK3 | 2.29974987 |
| 16 | PRPF4B | 2.21926835 |
| 17 | MATK | 2.13916868 |
| 18 | JAK1 | 2.04666178 |
| 19 | EPHB1 | 1.95077963 |
| 20 | PIK3CA | 1.89666149 |
| 21 | TXK | 1.76839450 |
| 22 | IKBKB | 1.76357192 |
| 23 | FGFR4 | 1.75113552 |
| 24 | CSK | 1.60724494 |
| 25 | IRAK3 | 1.59217635 |
| 26 | CDC42BPA | 1.58599600 |
| 27 | FGR | 1.50701142 |
| 28 | KSR2 | 1.48352886 |
| 29 | TAOK3 | 1.41806967 |
| 30 | MAP3K13 | 1.36695792 |
| 31 | ZAP70 | 1.33797413 |
| 32 | EPHA3 | 1.31117466 |
| 33 | CSF1R | 1.29399057 |
| 34 | SYK | 1.22092109 |
| 35 | MST4 | 1.19644655 |
| 36 | NME2 | 1.18824867 |
| 37 | KDR | 1.16125314 |
| 38 | HCK | 1.15061923 |
| 39 | LYN | 1.12813004 |
| 40 | BMX | 1.11934567 |
| 41 | MAP3K1 | 1.09368390 |
| 42 | TRIB3 | 1.08717945 |
| 43 | MAP3K2 | 1.06784425 |
| 44 | BTK | 1.06207451 |
| 45 | MAP2K2 | 1.03528694 |
| 46 | JAK2 | 1.01086175 |
| 47 | TGFBR2 | 1.00949799 |
| 48 | FES | 0.98926166 |
| 49 | PRKG2 | 0.93660816 |
| 50 | MET | 0.92679178 |
| 51 | LCK | 0.91713224 |
| 52 | PTK6 | 0.91310887 |
| 53 | FGFR3 | 0.90449574 |
| 54 | DDR2 | 0.85044243 |
| 55 | RPS6KA4 | 0.84979520 |
| 56 | CHUK | 0.84836767 |
| 57 | IRAK1 | 0.84748776 |
| 58 | TNK2 | 0.83199900 |
| 59 | MAP3K11 | 0.82559281 |
| 60 | MAP3K5 | 0.79669406 |
| 61 | ABL2 | 0.76955226 |
| 62 | TESK2 | 0.76625916 |
| 63 | MAP2K3 | 0.75408475 |
| 64 | ARAF | 0.73499694 |
| 65 | ADRBK2 | 0.71959861 |
| 66 | TEC | 0.71800520 |
| 67 | SIK3 | 0.69638014 |
| 68 | PIM1 | 0.69555272 |
| 69 | SIK1 | 0.69138576 |
| 70 | TIE1 | 0.66852687 |
| 71 | HIPK2 | 0.66644740 |
| 72 | MAP2K6 | 0.66427916 |
| 73 | RIPK1 | 0.65851528 |
| 74 | TGFBR1 | 0.65132007 |
| 75 | TLK1 | 0.63984398 |
| 76 | PRKD2 | 0.62446718 |
| 77 | CLK1 | 0.62050748 |
| 78 | MAPK7 | 0.58224214 |
| 79 | TESK1 | 0.56622667 |
| 80 | ACVR1B | 0.55462672 |
| 81 | PRKCD | 0.54379891 |
| 82 | DAPK3 | 0.54322923 |
| 83 | PDPK1 | 0.53695919 |
| 84 | EGFR | 0.52549662 |
| 85 | MARK2 | 0.52236554 |
| 86 | DYRK1B | 0.50139730 |
| 87 | STK10 | 0.49505829 |
| 88 | PDK1 | 0.48825771 |
| 89 | MARK3 | 0.48723305 |
| 90 | MAP3K3 | 0.47526615 |
| 91 | EIF2AK2 | 0.47437725 |
| 92 | NUAK1 | 0.44386914 |
| 93 | ABL1 | 0.44153536 |
| 94 | DYRK3 | 0.42955218 |
| 95 | BMPR2 | 0.42669792 |
| 96 | MUSK | 0.42429284 |
| 97 | LRRK2 | 0.39792330 |
| 98 | MAP3K6 | 0.38844265 |
| 99 | MAP3K12 | 0.38188429 |
| 100 | MAP2K1 | 0.37450691 |
| 101 | IRAK2 | 0.36566881 |
| 102 | FYN | 0.35035667 |
| 103 | NEK9 | 0.34331948 |
| 104 | MAP3K8 | 0.31480163 |
| 105 | YES1 | 0.31461013 |
| 106 | MAPK11 | 0.30710899 |
| 107 | RPS6KL1 | 0.28733495 |
| 108 | RPS6KC1 | 0.28733495 |
| 109 | PIK3CG | 0.28698654 |
| 110 | MAPKAPK2 | 0.28448207 |
| 111 | TRPM7 | 0.28296680 |
| 112 | PKN1 | 0.28013925 |
| 113 | PAK4 | 0.27639067 |
| 114 | STK24 | 0.26760593 |
| 115 | CAMK1D | 0.26390465 |
| 116 | MOS | 0.26335731 |
| 117 | EPHA2 | 0.25520870 |
| 118 | TAOK1 | 0.24446822 |
| 119 | GRK6 | 0.24388932 |
| 120 | DAPK2 | 0.24099421 |
| 121 | ICK | 0.23120627 |
| 122 | IGF1R | 0.23064848 |
| 123 | SRC | 0.22631906 |
| 124 | TTN | 0.22361906 |
| 125 | RET | 0.21466464 |
| 126 | CDK6 | 0.20286815 |
| 127 | STK4 | 0.20228126 |
| 128 | MAP3K10 | 0.20168212 |
| 129 | GRK7 | 0.19804035 |
| 130 | MAPK4 | 0.16825840 |
| 131 | ALK | 0.16472504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.31798744 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.10207800 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.87479443 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85123784 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.84555951 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.58514502 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.44967046 |
| 8 | Influenza A_Homo sapiens_hsa05164 | 2.31897097 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.23304724 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.22229764 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21109848 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14084962 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13327709 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.12131360 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.11180549 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.10892447 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.05082500 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.98624463 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91492914 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.89496856 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88566800 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.82500029 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.76786459 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74356648 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71001730 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67580045 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66407822 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.64589911 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61156555 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57390421 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.54666350 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.53497112 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51491952 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39526169 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28508896 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25100001 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.25040265 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21526090 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18598902 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18302850 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.10810105 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08840577 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07616815 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06855328 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.05861700 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01379643 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00263303 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92928888 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91133277 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85464437 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.84556136 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84180856 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83071510 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81784078 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81083226 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.79593250 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76942279 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76121934 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72803021 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72205995 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.69519079 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68128326 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67065875 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66240030 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65693285 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65590129 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62155697 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58515808 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57324388 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56489193 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.55657081 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55643012 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55146819 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54130257 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53934065 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51765179 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51219366 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49920222 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.49078882 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43860265 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43565215 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42747965 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.40070553 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38676979 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38484237 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38102292 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37818148 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37703825 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37200281 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37162601 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36781383 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36266078 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34544239 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.33314184 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32777402 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29588702 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29163237 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26747623 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26659535 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26228186 |
| 101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25705907 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24617663 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24307314 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21983757 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20541893 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19366267 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18867840 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.18772330 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18288533 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18002259 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15800167 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14792412 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.12388233 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12031965 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10994378 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.10981286 |

